Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creyos, formerly Cambridge Brain Sciences, is a private digital health company that provides a web-based platform for cognitive and behavioral health assessment in healthcare and research settings. Its products deliver scientifically validated online cognitive tasks and digitized questionnaires that help clinicians and researchers measure domains such as memory, attention, reasoning, executive function, and verbal ability. The company markets solutions for early detection, monitoring, documentation, and care planning across brain health use cases including dementia, mild cognitive impairment, ADHD, concussion, and behavioral health. Creyos also serves academic and commercial researchers with tools for large-scale remote or in-clinic cognitive data collection. The business is commercial-stage and generates revenue from software platform offerings rather than therapeutic drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creyos.